BRF
STLN

B. Riley Financial’s Starling Oncology STLN Stock Holding History

B. Riley Financial’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.03M Sell
742,593
-187,141
-20% -$786K 0.93% 4
2026
Q1 		$2.85M Buy
929,734
+266,358
+40% +$817K 0.63% 7
2025
Q4 		$2.36M Sell
663,376
-148,170
-18% -$550K 1.01% 6
2025
Q3 		$2.83M Buy
811,546
+349,546
+76% +$1.2M 1.92% 6
2025
Q2 		$947K Buy
462,000
+312,000
+208% +$780K 1.06% 10
2025
Q1 		$171K Buy
+150,000
New +$116K 0.22% 14

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

B. Riley Financial's STLN Position: Q2 2026 in Review

B. Riley Financial reduced its Starling Oncology (STLN) stake by 20% in Q2 2026, selling an estimated $786K and leaving 742,593 shares worth $4.03M. The position accounts for 0.93% of the portfolio, ranked #4.

B. Riley Financial first reported a position in STLN in Q1 2025 and has held it in 6 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • B. Riley Financial held 742,593 shares of Starling Oncology worth $4.03M as of Q2 2026.
  • B. Riley Financial sold 187,141 Starling Oncology shares in Q2 2026, an estimated $786K.
  • Starling Oncology made up 0.93% of B. Riley Financial's portfolio in Q2 2026, its #4 holding.
  • B. Riley Financial first reported a position in Starling Oncology in Q1 2025 and has held it in 6 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on B. Riley Financial's 13F filing for Q2 2026, filed 14 Aug 2026.